Primary Care Clinics in Corona Del Mar, CA Accepting Medicare
4 Primary Care Clinics found. Showing 1 - 4
 Roya Khodaie, Md Inc. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2865 E Coast Hwy Ste 150, Corona Del Mar, CA 92625 Phone: 703-477-7572 |
Rokhsareh Tajrishi Inc. Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 3334 E Coast Hwy, Suite 570, Corona Del Mar, CA 92625 Phone: 714-903-7767 Fax: 714-903-7801 |
Personalcare Physicians Of Irvine Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2121 E Coast Hwy Ste 250, Corona Del Mar, CA 92625 Phone: 949-706-3300 Fax: 949-706-3301 |
Personalcare Physicians Of Newport Beach Inc Family Medicine Medicare: Medicare Enrolled Practice Location: 2121 E Coast Hwy Ste 250, Corona Del Mar, CA 92625 Phone: 949-706-3300 Fax: 949-706-3301 |
News Archive
Mass. cutting ties with insurance exchange website vendor after problems
The contractor, CGI Group, is also the lead contractor on the federal marketplace website.
Doctors urge medical journals to incentivise academics to improve health information on Wikipedia
Wikipedia is the most read source of medical information by the general public, as well as medical students, doctors, and policymakers. Ensuring that it is accurate and complete is therefore of the utmost importance for global health since its content has immediate real-world health consequences.
Wash. regulations would restrict pain killer prescriptions; Texas Lt. Gov. bemoans costs associated with health law; Fla. insurance pilot project shows early success
The New York Times: "In an unusual move, a state government is developing regulations meant to stop doctors from prescribing higher doses of powerful — and often dangerous — pain killers for patients who are not benefiting from them. The effort, in Washington State, represents the most sweeping attempt yet to stem what some experts see as the excessive use of prescribed narcotics, and it is being closely watched by medical professionals elsewhere.
FDA clears Covidien's SpiderFX embolic protection device
Covidien, a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration (FDA) has cleared SpiderFX for the treatment of severely calcified lesions used in conjunction with plaque excision in arteries of the lower extremities. It is the only embolic protection device indicated for this treatment in the United States.
› Verified 4 days ago